Neurocrine

Neurocrine is beefing up its pipeline, splurging $50M on rights to an epilepsy drug
Endpoints
Mon, 12/2/19 - 10:35 am
Neurocrine
epilepsy
Xenon
XEN901
Acadia, Neurocrine See Stock Price Bump After Quarterly Earnings
Xconomy
Fri, 08/2/19 - 12:55 pm
earnings
Acadia
Neurocrine
Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s
Xconomy
Tue, 01/29/19 - 09:59 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
VY-AADC
gene therapy
Ingrezza-maker Neurocrine brings tardive dyskinesia awareness to the tube
Fierce Pharma
Fri, 01/25/19 - 11:06 pm
Neurocrine
tardive dyskinesia
television ads
Neurocrine down on Phase IIb Tourette syndrome miss
BioCentury
Wed, 12/12/18 - 06:38 pm
Neurocrine
Tourette's syndrome
valbenazine
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
Fierce Pharma
Thu, 11/15/18 - 11:39 pm
AbbVie
Orilissa
FDA
uterine fibroids
Neurocrine
Elagolix review extended
Tue, 04/10/18 - 04:36 pm
FDA Requires More Time to Review Abbvie and Neurocrine Endometriosis Drug Elagolix
CP Wire
Tue, 04/10/18 - 09:30 am
AbbVie
Neurocrine
FDA
Elagolix
endometriosis
Watch These Biotechs and the FDA Calendar
TheStreet.com
Sun, 02/11/18 - 01:23 pm
FDA
biotech
Dynavax
HEPLISAV-B
Progenics
Azedra
Neurocrine
Elagolix
AbbVie
New Neurocrine, Teva meds win doctors' praise, fueling bigger sales expectations
Fierce Pharma
Wed, 10/11/17 - 11:02 am
Neurocrine
Teva Pharmaceutical
physicians
Ingrezza
Austedo
tardive dyskinesia
Teva takes on Neurocrine with TD nod for Austedo
Fierce Pharma
Thu, 08/31/17 - 09:26 am
Teva Pharmaceutical
Neurocrine
Austedo
tardive dyskinesia
FDA
Hard charging Neurocrine hit with a sudden setback as Tourette study flops
Endpoints
Wed, 05/24/17 - 10:38 am
Neurocrine
Tourette's syndrome
Ingrezza
Neurocrine Biosciences’ new drug may cost patients more than $10,000 a month, twice as much as expected
Marketwatch
Thu, 04/27/17 - 09:14 am
Neurocrine
drug pricing
Ingrezza
tardive dyskinesia
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
drug discounts
drug pricing
Roche
Neurocrine
Sanofi
Regeneron
Tesaro
Novartis
Neurocrine Biosciences Snags U.S. Approval for Movement Disorder Drug
TheStreet.com
Wed, 04/12/17 - 11:48 am
Neurocrine
tardive dyskinesia
Ingrezza
4 Drug Stocks With Big News Coming in April
Motley Fool
Tue, 04/4/17 - 12:11 am
Neurocrine
Incyte
Eli Lilly
Biomarin
Ingrezza
baricitinib
Brineura
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Endpoints
Thu, 02/9/17 - 09:24 pm
Neurocrine
Parkinson's Disease
Ongentys
Bial
Neurocrine's Tourette drug misses mark in mid-stage trial
BioPharma Dive
Fri, 01/20/17 - 09:42 am
Neurocrine
Tourette's syndrome
clinical trials
Ingrezza
Pfizer's Medivation buy seen prescribing more biotech M&A
Yahoo/Reuters
Mon, 08/22/16 - 10:30 pm
Pfizer
Medivation
M&A
biotech
Vertex Pharmaceuticals
Alexion
Neurocrine
Intercept Pharma
Teva’s Huntington Drug Hits A Snag, Lifting Rival Neurocrine
Investors.com
Wed, 06/1/16 - 10:14 am
Teva Pharmaceutical
Huntington's disease
Neurocrine
SD-809
valbenazine

Pages